Evidence map›Paper›PMID 30327580›Full record

ArticleMediators of inflammation2018

Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease.

Anna Hernández-Aguilera, Salvador Fernández-Arroyo, Noemí Cabre, Fedra Luciano-Mateo, Gerard Baiges-Gaya, Montserrat Fibla, Vicente Martín-Paredero, Javier A Menendez, Jordi Camps, Jorge Joven

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Anna Hernández-AguileraUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, C. Sant Joan s/n, 43201 Reus, Spain.ORCID 0000-0003-0954-295X
Salvador Fernández-ArroyoUniversitat Rovira i Virgili, C. Escorxador s/n, 43003 Tarragona, Spain.
Noemí CabreUniversitat Rovira i Virgili, C. Escorxador s/n, 43003 Tarragona, Spain.
Fedra Luciano-MateoUniversitat Rovira i Virgili, C. Escorxador s/n, 43003 Tarragona, Spain.ORCID 0000-0002-8736-2455
Gerard Baiges-GayaUniversitat Rovira i Virgili, C. Escorxador s/n, 43003 Tarragona, Spain.
Montserrat FiblaUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, C. Sant Joan s/n, 43201 Reus, Spain.
Vicente Martín-ParederoDepartment of Vascular Surgery, Hospital Universitari Joan XXIII, C/ Dr. Mallafré Guasch 4, 43005 Tarragona, Spain.
Javier A MenendezProgram Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.ORCID 0000-0001-8733-4561
Jordi CampsUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, C. Sant Joan s/n, 43201 Reus, Spain.ORCID 0000-0002-3165-3640
Jorge JovenUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, C. Sant Joan s/n, 43201 Reus, Spain.
Institut de Recerca Biomèdica Catalunya Sud · ESUniversitat Rovira i Virgili · ESHospital Universitari Joan XXIII de Tarragona · ESInstitut Català d'Oncologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral artery disease (PAD) is a common disease affecting 20-25% of population over 60 years old. Early diagnosis is difficult because symptoms only become evident in advanced stages of the disease. Inflammation, impaired metabolism, and mitochondrial dysfunction predispose to PAD, which is normally associated with other highly prevalent and related conditions, such as diabetes, dyslipidemia, and hypertension. We have measured energy-balance-associated metabolite concentrations in the plasma of PAD patients segregated by the severity of the disease and in plasma of healthy volunteers using a quantitative and targeted metabolomic approach. We found relevant associations between several metabolites (3-hydroxybutirate, aconitate, (iso)citrate, glutamate, and serine) with markers of oxidative stress and inflammation. Metabolomic profiling also revealed that (iso)citrate and glutamate are metabolites with high ability to discriminate between healthy participants and PAD patients without symptoms. Collectively, our data suggest that metabolomics provide significant information on the pathogenesis of PAD and useful biomarkers for the diagnosis and assessment of progression.

Indexed as

AryldialkylphosphataseBiomarkersChemokine CCL2Cross-Sectional StudiesEnergy MetabolismHumansMetabolomicsOxidative StressPeripheral Arterial DiseaseAryldialkylphosphataseBiomarkersCCL2 protein, humanChemokine CCL2PON1 protein, human

Identifiers

PMID30327580
PMCPMC6171256
OpenAlexW2889753726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.